Table 2.
Details of Demographic and Clinico-Pathological Characteristics of Breast Cancer Patients Enrolled in the Study
| Variables | Number | Percentage (%) |
|---|---|---|
| Total Number of patients | 200 | |
| Age (Mean ± SD) years | 50.24 ±10.93 | (Range:18-85) Median:48 |
| ≤ 50 | 118 | 59 |
| >50 | 82 | 41 |
| BMI Kg/m2 | ||
| <25 | 122 | 61 |
| 25-30 | 62 | 31 |
| >30 | 16 | 8 |
| Tobacco smoking Status | ||
| Tobacco users | 109 | 54.5 |
| Tobacco no users | 91 | 45.5 |
| Family history of Cancer | ||
| Yes | 50 | 25 |
| No | 150 | 75 |
| Tumor localization | ||
| Left breast | 102 | 51 |
| Right breast | 98 | 49 |
| Tumor size in cm | ||
| ≤ 2 | 105 | 52.5 |
| > 2 | 95 | 47.5 |
| Histological Grade | ||
| I, II | 107 | 53.5 |
| III, IV | 93 | 46.5 |
| Clinical TNM Stage | ||
| I | 4 | 2 |
| II | 98 | 49 |
| III | 80 | 40 |
| IV | 18 | 9 |
| Histopathological TNM Stage | ||
| I | 2 | 1 |
| II | 88 | 44 |
| III | 90 | 45 |
| IV | 20 | 10 |
| Hormone Receptor Status | ||
| ER/ PR+ve | 83 | 41.5 |
| ER/ PR-ve | 109 | 54.5 |
| ER/PR/Her2+ve | 6 | 3 |
| ER/PR/Her2-ve | 85 | 42.5 |
| ER/ PR+ve Her2-ve | 78 | 39 |
| ER/ PR-ve Her2+ve | 24 | 12 |
| Chemotherapy | ||
| Adjuvant chemotherapy | 155 | 77.5 |
| Neo-Adjuvant chemotherapy | 31 | 15.5 |
| Palliative chemotherapy | 14 | 7 |
| Radiotherapy | ||
| Adjuvant RT | 81 | 40.5 |
| No Adjuvant RT | 119 | 59.5 |